If Wegovy Isn't Working For You, Here's What's Most Likely Happening

The biggest misconception: slow progress means the medicine isn't working

Most people who say Wegovy is not working for them arrive at that conclusion somewhere between weeks four and twelve, usually while still on a starter dose. That frustration is completely understandable. But the titration schedule exists for a reason: the body needs time to adjust, and the early doses (0.25mg and 0.5mg) are there to reduce side effects, not to produce significant weight loss. The therapeutic doses come later.

In the STEP 1 trial, published in the New England Journal of Medicine, participants on 2.4mg semaglutide lost an average of around 15% of their body weight over 68 weeks, but that loss was gradual and uneven throughout the study. There were clear plateau periods where the scales barely moved for several weeks at a time, followed by further loss. That pattern is typical, and it's one of the things our clinical team at nume sees most consistently: people interpret a plateau as failure when it's often just biology doing what biology does.

The NHS medicines page for semaglutide notes that weight loss results vary between individuals. That's not hedging, it reflects real variation in how people respond, driven by genetics, gut hormone sensitivity and metabolic history.

What can genuinely reduce Wegovy's effectiveness

There are practical factors that blunt semaglutide's effect, and they're worth being honest about. Calorie intake is the obvious one: Wegovy suppresses appetite significantly for most people, but appetite suppression doesn't automatically translate into a large calorie deficit if portion sizes haven't changed much, or if calories are coming mainly from drinks, snacks or alcohol, which tend to bypass the fullness signal the medicine produces.

Medication timing matters too. Taking the injection consistently on the same day each week keeps blood levels stable. Missing a dose, then doubling up informally, disrupts that consistency in ways that affect how well the medicine works. The same applies to the Wegovy pill: taking oral semaglutide anything other than first thing in the morning on an empty stomach, with a small amount of plain water, and waiting at least 30 minutes before food or coffee, significantly reduces absorption. People who keep their tablet next to the kettle as a morning reminder (rather than in a handbag or gym bag) tend to find the routine easier to stick to.

Sleep quality, chronic stress and certain medications can also interact with how GLP-1 medicines work. If you're on other treatments, a prescriber reviewing your full picture is the right starting point, not switching medicines independently.

When a genuine non-response is possible, and what to do

A minority of people on semaglutide see less response than average, and that's not a personal failing. Biological variation in GLP-1 receptor sensitivity is real. The question is what counts as enough time and enough dose before concluding the medicine isn't right for you specifically.

NICE guidance on semaglutide (Wegovy) states clearly that if there's been fewer than 5% weight loss after six months at the maintenance dose, the clinical case for continuing should be reviewed. That's the formal benchmark, six months at maintenance, not six weeks on a starter dose. If you're not there yet, it may simply be too early to judge.

Some people who find Wegovy isn't producing results do respond better to tirzepatide, the dual GIP and GLP-1 receptor agonist licensed in the UK as Mounjaro. In the SURMOUNT-5 head-to-head trial, tirzepatide produced greater average weight loss than semaglutide 2.4mg over 72 weeks. Whether a switch would suit you is a clinical decision, one worth raising directly with a prescriber rather than guessing.

If you've been wondering why Wegovy isn't working for you specifically, the honest answer is that the reasons are usually identifiable, often addressable, and nearly always worth discussing before concluding the treatment has failed. There's a dedicated page covering why semaglutide may not be working for you, which walks through the most common explanations and what to do about each one. A prescriber can look at your dose history, your progress data and your full health picture in a way that no article can.

For a broader look at how long results typically take to appear, the timeline for Wegovy to work is worth reading alongside this. And if you're weighing up whether semaglutide is the right medicine for your situation at all, the Wegovy overview covers the full licensed picture, including eligibility and what the clinical trials showed across different groups.

Cost is sometimes a factor in whether people persist with treatment long enough to reach maintenance dose. If that's relevant for you, the cost of Wegovy in the UK sets out what's typically included in a legitimate private prescription and what to watch out for. When you're ready to speak to a prescriber, check your eligibility with our clinical team, the consultation is free, and a real clinician reviews it the same day.